Stable Incidence and Increasing Prevalence of Primary Hyperparathyroidism in a Population-based Study in Scotland
Open Access
- 6 April 2023
- journal article
- research article
- Published by The Endocrine Society in The Journal of Clinical Endocrinology & Metabolism
- Vol. 108 (10) , e1117-e1124
Abstract
Context: Previous studies, including our own, have demonstrated a highly variable incidence of primary hyperparathyroidism (PHPT) from year to year. Objective: We planned to provide a current estimate of the incidence and prevalence of PHPT in a community-based study. Methods: A population-based retrospective follow-up study was conducted in Tayside (Scotland) from 2007 to 2018. Record-linkage technology (demography, biochemistry, prescribing, hospital admissions, radiology, and mortality data) was used to identify all patients. Cases of PHPT were defined as those with at least 2 raised serum corrected calcium concentration CCA (> 2.55 mmol/L) and/or hospital admissions with PHPT diagnoses and/or surgery records with parathyroidectomy during the follow-up period. The number of prevalent and incident cases of PHPT per calendar year by age and sex were estimated. Results: A total of 2118 people (72.3% female, mean age 65 years) were identified with an incident case of PHPT. The overall prevalence of PHPT over the 12 years of the study was 0.84% (95% CI, 0.68%-1.02%), steadily increasing from 0.71% in 2007 to 1.02% in 2018. From 2008, the incidence of PHPT was relatively stable from 4 to 6 cases per 10 000 person-years, declining from 11.5 per 10 000 person-years in 2007. The incidence varied from 0.59 per 10 000 person-years (95% CI, 0.40%-0.77%) for those aged 20 to 29 years, to 12.4 per 10 000 person-years (95% CI, 11.2%-13.3%) in those aged 70 to 79 years. Incidence of PHPT was 2.5 times higher in women than in men. Conclusion: This study is the first showing a relatively steady annual incidence of PHPT at 4 to 6 per 10 000 person-years. This population-based study reports a PHPT prevalence of 0.84%.Keywords
Funding Information
- NHS Tayside Research Endowments
This publication has 26 references indexed in Scilit:
- Cancer-Related HypercalcemiaJournal of Oncology Practice, 2016
- Thiazide-Associated Hypercalcemia: Incidence and Association With Primary Hyperparathyroidism Over Two DecadesThe Journal of Clinical Endocrinology & Metabolism, 2016
- Secular trends in the incidence of primary hyperparathyroidism over five decades (1965–2010)Bone, 2015
- Current Issues in the Presentation of Asymptomatic Primary Hyperparathyroidism: Proceedings of the Fourth International WorkshopThe Journal of Clinical Endocrinology & Metabolism, 2014
- The prevalence of undiagnosed and unrecognized primary hyperparathyroidism: A population-based analysis from the electronic medical recordSurgery, 2013
- Incidence and Prevalence of Primary Hyperparathyroidism in a Racially Mixed PopulationThe Journal of Clinical Endocrinology & Metabolism, 2013
- A record linkage study of outcomes in patients with mild primary hyperparathyroidism: The Parathyroid Epidemiology and Audit Research Study (PEARS)Clinical Endocrinology, 2011
- Insulin Resistance Before and After Parathyroidectomy in Patients with Primary Hyperparathyroidism—a Pilot StudyEndocrine Research, 2010
- Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UKClinical Endocrinology, 2009
- Incidence of Primary Hyperparathyroidism in Rochester, Minnesota, 1993–2001: An Update on the Changing Epidemiology of the DiseaseJournal of Bone and Mineral Research, 2006